AllianceBernstein
LOXO

AllianceBernstein’s Loxo Oncology, Inc LOXO Stock Holding History

AllianceBernstein’s Portfolio LOXO Stock Details LOXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-508,691
Closed -$71.3M – 3168
2018
Q4 		$71.3M Sell
508,691
-65,445
-11% -$9.93M 0.05% 345
2018
Q3 		$98.1M Buy
574,136
+96,335
+20% +$16.2M 0.06% 311
2018
Q2 		$82.9M Sell
477,801
-85,145
-15% -$12.8M 0.06% 359
2018
Q1 		$64.9M Sell
562,946
-147,794
-21% -$15.7M 0.05% 416
2017
Q4 		$59.8M Sell
710,740
-145,147
-17% -$12.1M 0.04% 433
2017
Q3 		$78.8M Sell
855,887
-80,903
-9% -$6.29M 0.06% 361
2017
Q2 		$75.1M Buy
936,790
+312,988
+50% +$17.3M 0.06% 365
2017
Q1 		$26.3M Buy
623,802
+614,102
+6,331% +$25.3M 0.02% 653
2016
Q4 		$312K Hold
9,700
– – ﹤0.01% 2729
2016
Q3 		$254K Buy
9,700
+900
+10% +$23.5K ﹤0.01% 2759
2016
Q2 		$204K Buy
+8,800
New +$219K ﹤0.01% 2799

Other funds holding LOXO

IUHSA
Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

AllianceBernstein's LOXO Position: Q1 2019 in Review

AllianceBernstein sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 508,691 shares — an estimated $71.3M sold.

AllianceBernstein first reported a position in LOXO in Q2 2016 and held it in 11 quarters. The position peaked at $98.1M in Q3 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

  • AllianceBernstein reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
  • AllianceBernstein sold 508,691 Loxo Oncology, Inc shares in Q1 2019, an estimated $71.3M.
  • AllianceBernstein first reported a position in Loxo Oncology, Inc in Q2 2016 and held it in 11 quarters.
  • AllianceBernstein's Loxo Oncology, Inc position peaked at $98.1M in Q3 2018.
  • 1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on AllianceBernstein's 13F filing for Q1 2019, filed 14 May 2019.